Follow the Pundits
Tag: Growth Stocks
Revisiting The Case of CRISPR Therapeutics: Still Crisp, Still Risky, Still Dangerously Alluring
CRISPR Therapeutics (CRSP) has the first widely approved CRISPR-based therapy, huge insider buying near today’s price, and institutions (including ARK) deep in the name — while shorts pile on. Crisp setup, risky execution, dangerously alluring upside. 🧬🎯
Alfred Lin of Sequoia Capital Buys $100 Million Worth of DoorDash Stock. Will The Shares Deliver?
When Sequoia’s Alfred Lin drops a $100M insider buy on DoorDash, investors pay attention. DASH is growing fast, expanding globally, and courting robots — but is the stock about to deliver… or disappoint?
Key Director and Bessemer Partner Buys Over $5M of ACV Auctions: Time to Bid, or Just Mor-Bid Curiosity?
A major insider just snapped up 912,408 shares of ACV Auctions—over $5.1 million worth. Institutions are stuffed with shares, revenue is growing nearly 20%, and profits are inching closer. Should investors bid… or back away slowly?
Institutions & Hedge Funds Are Buying and The Stock Is on a Tear. Will Robinhood (HOOD) Keep Stealing the Show?
Robinhood isn’t just stealing trades — it’s stealing headlines. With institutions buying, hedge funds betting, and analysts raising targets, HOOD is on a tear. But can the show go on? 🎟️🔥
Will Billionaire Investor Ron Baron's Investment in Figs, Inc. (FIGS) Finally Bear Fruit?
Billionaire investor Ron Baron is doubling down on Figs, Inc. (FIGS) 🧵—the scrubs brand he calls the “Lululemon of healthcare.” With 94% institutional ownership, growing global expansion, and strong financials, could FIGS finally bear fruit 🍇? Or will competition and lofty valuation trip it up? Here’s the breakdown—fun, funny, and icon-filled.
Can Uber Deliver (And Can Your Portfolio Take a Ride?)
Uber just became Bill Ackman’s #1 bet. With strong earnings, growing free cash flow, and big-time institutional backing, could your portfolio use a lift too? Let’s find out—emojis, wit, and wisdom included.
🚗💼 Bill Ackman’s Pershing Square: Betting Big, Driving Hertz, and Not Crashing the Portfolio
Bill Ackman’s Pershing Square has made headlines again—this time for a turbo-charged bet on Hertz that’s now doubled in value. But this isn’t a one-hit wonder. From fast food giants to activist showdowns, Ackman’s concentrated strategy, sharp risk management, and occasional billion-dollar “oopsies” make him one of Wall Street’s most compelling players.